You have 9 free searches left this month | for more free features.

Antithrombins

Showing 1 - 25 of 38

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Evaluation of Risk Factors and Outcome of Thrombosis in Children

Not yet recruiting
  • Thrombosis in Children
  • complete blood count
  • Sohag, Egypt
    Sohag University hospitals
Apr 30, 2023

Acquired Antithrombin Deficiency Trial (Human plasma derived antithrombin, Placebo)

Not yet recruiting
  • Acquired Antithrombin Deficiency
  • Human plasma derived antithrombin
  • Placebo
  • (no location specified)
Oct 17, 2023

Hemophilia A Trial (Fitusiran (SAR439774), Clotting factor concentrates (CFC) or bypassing agents (BPA), Antithrombin

Not yet recruiting
  • Hemophilia A
  • Fitusiran (SAR439774)
  • +3 more
  • (no location specified)
Nov 17, 2023

Antithrombin III Deficiency in Adult Patients With ECMO

Completed
  • Antithrombin III Deficiency
  • Extracorporeal Membrane Oxygenation Complication
  • Antithrombin III
  • Istanbul, Turkey
    Istanbul Dr.Siyami Ersek Thoracic and Cardiovascular Surgery Tra
May 22, 2022

Portal Vein Thrombosis, Cirrhosis, Liver Trial in Hershey (Antithrombin III, Placebo)

Withdrawn
  • Portal Vein Thrombosis
  • Cirrhosis, Liver
  • Antithrombin III
  • Placebo
  • Hershey, Pennsylvania
    Penn State College of Medicine
Feb 23, 2022

Hemophilia Trial in Orange (Fitusiran, Clotting factor concentrates (CFC) or bypassing agents (BPA), Antithrombin concentrate

Recruiting
  • Hemophilia
  • Orange, California
    Center for Inherited Blood Disorders (CIBD)-Site Number:8400012
Feb 2, 2023

Antithrombin III Treatment in Severe COVID-19 Infection

Active, not recruiting
  • Covid19
  • Antithrombin III
  • Innsbruck, Austria
  • +5 more
Aug 1, 2022

Liver Transplantation and Antithrombin Trial in Seoul (Antithrombin III)

Completed
  • Liver Transplantation and Antithrombin
  • Antithrombin III
  • Seoul, Korea, Republic of
    Asan Medical Center
May 30, 2021

Nutritional Requirements Trial in Columbus (Zero hard-boiled egg at 0 h, One hard-boiled egg at 0 h, Two hard-boiled eggs at 0

Recruiting
  • Nutritional Requirements
  • Zero hard-boiled egg at 0 h
  • +5 more
  • Columbus, Ohio
    Ohio State University
Dec 16, 2022

Preeclampsia Trial in Japan (Antithrombin gamma, physiological saline)

Recruiting
  • Preeclampsia
  • Antithrombin gamma
  • physiological saline
  • Nagoya, Aichi, Japan
  • +62 more
Nov 16, 2022

New Oral Direct Anticoagulants in Patients 80 Years Old and Over

Completed
  • Atrial Fibrillation
  • Plasma drug concentrations
  • Ivry-sur-Seine, Île-de-France, France
  • +1 more
Aug 26, 2021

Hepatic Veno-Occlusive Disease Trial in Seoul (Freeze-dried Concentrated Human Antithrombin ? 500 IU)

Active, not recruiting
  • Hepatic Veno-Occlusive Disease
  • Freeze-dried Concentrated Human Antithrombin Ⅲ 500 IU
  • Seoul, Chongno-gu, Korea, Republic of
    Seoul National University Hospital
Mar 28, 2021

Non-Hodgkin Lymphoma, Relapsed/Refractory Diffuse Large B-cell Lymphoma Trial in United States (NKTR-255 at 1.5 µg/kg, NKTR-255

Recruiting
  • Non-Hodgkin Lymphoma
  • Relapsed/Refractory Diffuse Large B-cell Lymphoma
  • NKTR-255 at 1.5 µg/kg
  • +3 more
  • La Jolla, California
  • +26 more
Jan 10, 2023

Covid19, Severe Acute Respiratory Syndrome, Distress Respiratory Syndrome Trial in Córdoba (Antithrombin + best available

Completed
  • Covid19
  • +2 more
  • Antithrombin + best available treatment
  • Best available treatment
  • Córdoba, Spain
    Hospital Universitario Reina Sofía
Feb 8, 2021

Raloxifene, Postmenopausal Women Trial (coagulation system parameters; factor 8, von Willebrand factor, protein C, protein S,

Completed
  • Raloxifene
  • Postmenopausal Women
  • coagulation system parameters; factor 8, von Willebrand factor, protein C, protein S, antithrombin III and fibrinogen were studied.
  • (no location specified)
Jul 2, 2020

Liver Cirrhosis Trial in Berne (Rivaroxaban 10 mg Oral Tablet, Apixaban 2.5 mg Oral Tablet)

Recruiting
  • Liver Cirrhosis
  • Rivaroxaban 10 mg Oral Tablet
  • Apixaban 2.5 mg Oral Tablet
  • Berne, Switzerland
    Department of Visceral Surgery and Medicine, University Hospital
May 21, 2021

Disseminated Intravascular Coagulation Trial (Antithrombin alfa (INN name), Control (Standard treatment))

Terminated
  • Disseminated Intravascular Coagulation
  • Antithrombin alfa (INN name)
  • Control (Standard treatment)
  • (no location specified)
Aug 5, 2021

STEMI - ST Elevation Myocardial Infarction Trial (Bivalirudin, Heparin)

Unknown status
  • STEMI - ST Elevation Myocardial Infarction
  • (no location specified)
Dec 6, 2019

Reperfusion Injury Trial in Leuven (Antithrombin-III, Infliximab, Apotransferrin)

Completed
  • Reperfusion Injury
  • Leuven, Belgium
    University Hospitals Leuven
Aug 8, 2019

Extracorporeal Membrane Oxygenation Trial in Milano (Antithrombin supplementation, No antithrombin supplementation)

Completed
  • Extracorporeal Membrane Oxygenation
  • Antithrombin supplementation
  • No antithrombin supplementation
  • Milano, MI, Italy
    Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico
May 15, 2019

Extracorporeal Membrane Oxygenation Complication, Cardiopulmonary Bypass Trial in Cincinnati (Antithrombin III)

Completed
  • Extracorporeal Membrane Oxygenation Complication
  • Cardiopulmonary Bypass
  • Antithrombin III
  • Cincinnati, Ohio
    Cincinnati Childrens Hospital Medical Center
Jan 24, 2019

ATIII Deficiency Trial in Durham (Anti-thrombin III, Placebo)

Completed
  • ATIII Deficiency
  • Anti-thrombin III
  • Placebo
  • Durham, North Carolina
    Duke University
Nov 21, 2019

Haemostatic Imbalance in Patients With Chronic Liver Disease

Unknown status
  • Haemostasis Imbalance in Chronic Liver Disease
  • Laboratory investigations ( protein C, protein S , antithrombin III)
  • (no location specified)
Jul 16, 2018

Cardiac Surgery, Cardiopulmonary Bypass Trial in United States (AT-III (Human), Placebo)

Completed
  • Cardiac Surgery
  • Cardiopulmonary Bypass
  • AT-III (Human)
  • Placebo
  • Orange, California
  • +40 more
Feb 27, 2019

Antithrombin III Deficiency Trial in Gothenburg (Atenativ)

Withdrawn
  • Antithrombin III Deficiency
  • Gothenburg, Sweden
    Dept Obstetrics, Sahlgrenska University Hospital
Sep 22, 2017